Who donated $2 billion dollars?

Phil Knight and Penny Knight Pledge $2 Billion to Cancer Research

It’s not every day that a single act of generosity redefines the landscape of medical research. But in December 2025, Nike cofounder Phil Knight, alongside his wife, Penny, made history with a monumental $2 billion pledge to advance cancer research—one of the largest charitable donations ever recorded.

Known as much for his quiet demeanor as for his revolutionary impact on sportswear, Knight has long supported education and health initiatives. This latest gift, however, stands apart—not just in scale, but in potential. While the specific institutions and research programs set to benefit are still being detailed, early reports suggest the funds will focus on accelerating breakthroughs in early detection, immunotherapy, and personalized treatment approaches.

“We’ve been lucky in so many ways,” Penny Knight said in a rare public statement. “Now we have a chance to give back in a way that could help millions.”

The donation arrives at a pivotal moment in oncology. With advancements in genomics and AI-driven diagnostics gaining momentum, the infusion of $2 billion could significantly shorten the timeline from lab discovery to real-world treatment. Experts call it a game-changer—not because it promises immediate cures, but because it provides the breathing room researchers often lack: long-term, flexible funding.

For Phil Knight, whose partnership with Bill Bowerman launched a global brand rooted in innovation, this gift feels like a quiet continuation of that legacy—just redirected from soles and swooshes to science and survival. Unlike the flash of a new sneaker drop, this move made no headlines at launch. No press event, no marketing campaign. Just a simple commitment, filed quietly, with the power to echo for decades.

In a world that often celebrates wealth for what it buys, Knight’s choice to give so much toward a future without cancer reminds us what it can truly be worth.